Latrepirdine Terminated Phase 3 Trials for Moderate to Severe Alzheimer's Disease Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00954590 | A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease |